Select Medical Holdings Director Sells $120,145 in Stock (SEM)
Select Medical Holdings (NYSE:SEM) Director Thomas Scully sold 8,533 shares of Select Medical Holdings stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $14.08, for a total transaction of $120,144.64. Following the completion of the transaction, the director now directly owns 143,389 shares of the company’s stock, valued at approximately $2,018,917. The sale was disclosed in a filing with the SEC, which is available at this link.
Select Medical Holdings (NYSE:SEM) traded up 1.16% on Tuesday, hitting $13.96. The stock had a trading volume of 823,426 shares. Select Medical Holdings has a 52-week low of $7.90 and a 52-week high of $16.17. The stock’s 50-day moving average is $15.25 and its 200-day moving average is $13.68. The company has a market cap of $1.815 billion and a P/E ratio of 15.70.
Select Medical Holdings (NYSE:SEM) last released its earnings data on Thursday, August 7th. The company reported $0.27 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.27. The company had revenue of $772.80 million for the quarter, compared to the consensus estimate of $777.16 million. During the same quarter in the previous year, the company posted $0.27 earnings per share. The company’s revenue for the quarter was up 2.1% on a year-over-year basis. Analysts expect that Select Medical Holdings will post $0.94 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, August 29th. Shareholders of record on Wednesday, August 20th will be given a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 2.87%. The ex-dividend date of this dividend is Monday, August 18th.
Select Medical Holdings Corporation is an operator of both specialty hospitals and outpatient rehabilitation clinics in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.